MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

ROCKVILLE, MD, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing innovative antibody-based therapeutics for the treatment of cancer, today announced that Eric Risser, President and CEO of MacroGenics, will present at the H.C. Wainwright 28th Annual Global Investment Conference on Wednesday, September 16, 2026, at 9:30 a.m. ET.

A webcast of the presentation may be accessed under "Events & Presentations" in the Investor Relations section of MacroGenics' website at http://ir.macrogenics.com/events.cfm. The Company will maintain an archived replay of the webcasts on its website for 30 days.

About MacroGenics, Inc.
MacroGenics (the Company) is a biopharmaceutical company focused on developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The Company generates its pipeline of product candidates primarily from its proprietary suite of next-generation antibody-based technology platforms, which have applicability across broad therapeutic domains. The combination of MacroGenics' technology platforms and protein engineering expertise has allowed the Company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies. For more information, please see the Company's website at www.macrogenics.com. MacroGenics, the MacroGenics logo are trademarks or registered trademarks of MacroGenics, Inc.

Contacts:

Jim Karrels, Senior Vice President, CFO
1-301-251-5172
[email protected] 

Argot Partners
1-212-600-1902
[email protected]

You May Also Be Interested In

• Men’s Care Clinic Featured Among 3 of the Best Men’s Health and Wellness Clinics in Toronto
• Warhound Launches with $200 Million to Rebuild America's Military Working Dog Supply, Using Advanced Genetics and Defense Technology
• PATRICK MAHOMES CALLED ON TO RENOUNCE ALL TIES TO PRIVATE JET PROVIDER AIRSHARE FOLLOWING 2023 AVIATION INCIDENT THAT RESULTED IN DANA HYDE'S DEATH